This trial will enroll 200 participants with schizophrenia who will be randomized to receive either an EAP-enhanced CR approach or a routine CR approach. The trial will use a repeated-measures design to assess outcomes after treatment and after a follow-up period. The primary outcome measure will be verbal learning, with functional capacity as the secondary outcome measure. EEG is exploratory and will examine neurophysiologic markers of need for and response to EAP training.